Literature DB >> 24549742

Periprocedural management of cardiac resynchronization therapy.

John Rickard1, Niraj Varma.   

Abstract

OPINION STATEMENT: Cardiac resynchronization therapy (CRT) is an important therapy in heart failure but 30 %‒40 % of patients may not respond. Improving this rate is an important goal and requires attention to candidate selection, intraoperative procedure, and postoperative follow-up. Factors to be considered are QRS morphology, duration, and left ventricular lead position with attention to paced effects on QRS. Postprocedure follow-up is critical to correct interfering conditions (eg, anodal capture, loss of 100 % biventricular pacing because of premature ventricular complexes (PVCs) or atrial fibrillation (AF). Echocardiographic improvement following CRT, which may take up to 18 months, is a potent predictor of long-term outcomes. Correcting the status of nonresponders, when possible, is important. Remote monitoring, in conjunction with CRT optimization clinics, may facilitate multidisciplinary follow-up and enable early intervention to improve outcome.

Entities:  

Year:  2014        PMID: 24549742     DOI: 10.1007/s11936-014-0298-1

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  65 in total

1.  2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).

Authors:  Michele Brignole; Angelo Auricchio; Gonzalo Baron-Esquivias; Pierre Bordachar; Giuseppe Boriani; Ole-A Breithardt; John Cleland; Jean-Claude Deharo; Victoria Delgado; Perry M Elliott; Bulent Gorenek; Carsten W Israel; Christophe Leclercq; Cecilia Linde; Lluís Mont; Luigi Padeletti; Richard Sutton; Panos E Vardas
Journal:  Europace       Date:  2013-06-24       Impact factor: 5.214

2.  Cardiac resynchronization therapy and the electrical substrate in heart failure: what does the QRS conceal?

Authors:  Niraj Varma
Journal:  Heart Rhythm       Date:  2009-03-31       Impact factor: 6.343

3.  Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial.

Authors:  Niraj Varma; Andrew E Epstein; Anand Irimpen; Robert Schweikert; Charles Love
Journal:  Circulation       Date:  2010-07-12       Impact factor: 29.690

4.  Characterization of super-response to cardiac resynchronization therapy.

Authors:  John Rickard; Dharam J Kumbhani; Zoran Popovic; David Verhaert; Mahesh Manne; Daniel Sraow; Bryan Baranowski; David O Martin; Bruce D Lindsay; Richard A Grimm; Bruce L Wilkoff; Patrick Tchou
Journal:  Heart Rhythm       Date:  2010-04-08       Impact factor: 6.343

5.  The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators.

Authors:  Matthew R Reynolds; David J Cohen; Aaron D Kugelmass; Phillip P Brown; Edmund R Becker; Steven D Culler; April W Simon
Journal:  J Am Coll Cardiol       Date:  2006-05-30       Impact factor: 24.094

Review 6.  The problem of non-response to cardiac resynchronization therapy.

Authors:  David H Birnie; Anthony Sl Tang
Journal:  Curr Opin Cardiol       Date:  2006-01       Impact factor: 2.161

7.  Radiographic left ventricular-right ventricular interlead distance predicts the acute hemodynamic response to cardiac resynchronization therapy.

Authors:  E Kevin Heist; Dali Fan; Theofanie Mela; Daniel Arzola-Castaner; Vivek Y Reddy; Moussa Mansour; Michael H Picard; Jeremy N Ruskin; Jagmeet P Singh
Journal:  Am J Cardiol       Date:  2005-09-01       Impact factor: 2.778

Review 8.  Device features for managing patients with heart failure.

Authors:  Niraj Varma; Bruce Wilkoff
Journal:  Heart Fail Clin       Date:  2011-04       Impact factor: 3.179

9.  Magnetic resonance imaging and response to cardiac resynchronization therapy: relative merits of left ventricular dyssynchrony and scar tissue.

Authors:  Nina Ajmone Marsan; Jos J M Westenberg; Claudia Ypenburg; Rutger J van Bommel; Stijntje Roes; Victoria Delgado; Laurens F Tops; Rob J van der Geest; Eric Boersma; Albert de Roos; Martin J Schalij; Jeroen J Bax
Journal:  Eur Heart J       Date:  2009-07-04       Impact factor: 29.983

10.  Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program.

Authors:  Wilfried Mullens; Richard A Grimm; Tanya Verga; Thomas Dresing; Randall C Starling; Bruce L Wilkoff; W H Wilson Tang
Journal:  J Am Coll Cardiol       Date:  2009-03-03       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.